JPRN-UMIN000006767
Completed
Phase 2
Phase II study of Carboplatin, Paclitaxel and Bevacizumab in patients with advanced Non-squamous non-small-cell lung cancer with large malignant pleural effusion. - Phase II study of Carboplatin, Paclitaxel and Bevacizumab in patients with advanced Non-squamous non-small-cell lung cancer with large malignant pleural effusion.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shizuoka Cancer Center
- Enrollment
- 32
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Actuve concomitant malignancy 2\) Massive pericardial effusion 3\) With rain metastasis, or tumor with large vessel invasion or cavity formation 4\) Episode of hemoptysis 5\) Those judged to be not suitable by the attending physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II Study of Paclitaxel and Carboplatin plus Bevacizumab in StageIIIA-N2, IIIB, IV patients with Nonsquamous Non-Small-Cell Lung Cancerchemotherapy-na&iumlve StageIIIA-N2, IIIB, IV patients with nonsquamous non-small-cell lung cancerJPRN-UMIN000006809Akita University Graduate School of Medicine31
Recruiting
Phase 2
Phase II Study of Nab-paclitaxel and Carboplatin Plus Bevacizumab as First-Line Chemotherapy for Reccurent or stage IIIB and IV Nonsquamous Non-Small-Cell Lung Cancer (ALCT004)on-squamous non-small-cell lung cancerJPRN-UMIN000013310Kyorin University School of Medicine33
Recruiting
Phase 1
Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLCJPRN-UMIN000020359Gunma University50
Completed
Phase 2
Phase II study of nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancerJPRN-UMIN000011681Gifu Municipal Hospital32
Completed
Phase 2
Phase2 study of Carboplatin / Paclitaxel + Bevacizumab to non-small-cell lung cancer (non-squamous cell carcinoma) with pleural efussion in stage4non-small-cell lung cancer (non-squamous cell carcinoma) with pleural efussion in stage4JPRN-UMIN000005284Osaka Prefectural Medical Center for Respiratory and Allergic diseases20